» Articles » PMID: 35317226

Role of the Nuclear Receptor Subfamily 4a in Mast Cells in the Development of Irritable Bowel Syndrome

Overview
Specialty Biotechnology
Date 2022 Mar 23
PMID 35317226
Authors
Affiliations
Soon will be listed here.
Abstract

The activation of mast cells (MCs) and mediator release are closely related to the pathophysiology of irritable bowel syndrome (IBS). However, the exact underlying mechanisms are still not completely understood. The nuclear receptor subfamily 4a (Nr4a) is a family of orphan nuclear receptors implicated in regulating MC activation, degranulation, cytokine/chemokine synthesis and release. Acute and chronic stress trigger hypothalamic-pituitaryadrenal axis (HPA) activation to induce the release of corticotropin-releasing hormone (CRH), resulting in MC activation and induction of the Nr4a family. Our newest data showed that Nr4a members were specially over-expressed in colonic MCs of the chronic water-avoidance stress (WAS)-induced visceral hyperalgesia mice, suggesting that Nr4a members might be involved in the pathophysiology of visceral hypersensitivity. In this review, we highlight the present knowledge on roles of Nr4a members in the activation of MCs and the pathophysiology of IBS, and discuss signaling pathways that modulate the activation of Nr4a family members. We propose that a better understanding of Nr4a members and their modulators may facilitate the development of more selective and effective therapies to treat IBS patients.

Citing Articles

Neural circuits regulating visceral pain.

Chang X, Zhang H, Chen S Commun Biol. 2024; 7(1):457.

PMID: 38615103 PMC: 11016080. DOI: 10.1038/s42003-024-06148-y.


Store-operated calcium entry mediates hyperalgesic responses during neuropathy.

Wang W, Wang Q, Huang J, Li H, Li F, Li X FEBS Open Bio. 2023; 13(11):2020-2034.

PMID: 37606998 PMC: 10626277. DOI: 10.1002/2211-5463.13699.


A Novel Mast Cell Stabilizer JM25-1 Rehabilitates Impaired Gut Barrier by Targeting the Corticotropin-Releasing Hormone Receptors.

Sun Y, Li H, Liu L, Bai X, Wu L, Shan J Pharmaceuticals (Basel). 2023; 16(1).

PMID: 36678544 PMC: 9866683. DOI: 10.3390/ph16010047.

References
1.
An S, Zong G, Wang Z, Shi J, Du H, Hu J . Activation of protease-activated receptor 4 of mast cells could downregulate proinflammatory cytokines in irritable bowel syndrome. Gut. 2017; 66(11):2040-2042. DOI: 10.1136/gutjnl-2016-313504. View

2.
Katagiri Y, Takeda K, Yu Z, Ferrans V, Ozato K, Guroff G . Modulation of retinoid signalling through NGF-induced nuclear export of NGFI-B. Nat Cell Biol. 2000; 2(7):435-40. DOI: 10.1038/35017072. View

3.
DCosta S, Ayyadurai S, Gibson A, Mackey E, Rajput M, Sommerville L . Mast cell corticotropin-releasing factor subtype 2 suppresses mast cell degranulation and limits the severity of anaphylaxis and stress-induced intestinal permeability. J Allergy Clin Immunol. 2018; 143(5):1865-1877.e4. PMC: 6802741. DOI: 10.1016/j.jaci.2018.08.053. View

4.
An S, Zong G, Wang Z, Shi J, Du H, Hu J . Expression of inducible nitric oxide synthase in mast cells contributes to the regulation of inflammatory cytokines in irritable bowel syndrome with diarrhea. Neurogastroenterol Motil. 2016; 28(7):1083-93. DOI: 10.1111/nmo.12811. View

5.
Zhao Y, Bruemmer D . NR4A orphan nuclear receptors: transcriptional regulators of gene expression in metabolism and vascular biology. Arterioscler Thromb Vasc Biol. 2010; 30(8):1535-41. PMC: 2907171. DOI: 10.1161/ATVBAHA.109.191163. View